FibroBiologics Inc. (NASDAQ: FBLG) reports enrolling first patients in its Phase 1/2 trial for CYWC628, a fibroblast-based therapy targeting diabetic foot ulcers.
TransCode Therapeutics announced successful completion of Phase 1a clinical trial for TTX-MC138, showing safety and disease stabilization in patients with advanced cancer.
Co-Diagnostics (Nasdaq: CODX) entered a joint venture with Arabian Eagle Manufacturing to develop and commercialize Co-Dx technologies in Saudi Arabia and other Middle East and North Africa countries.
Scienture Holdings, Inc. announced GPO agreements for its new drug, Arbli, providing access to over 2,500 healthcare institutions and plans to expand further.
DASH expands Commerce Platform with new tools for restaurants to increase sales and improve customer relationships. Includes loyalty and marketing programs, website creation, and CRM tools. Packages start at $0.
11 best performing large-cap stocks last week, including Symbotic, Nike, First Solar, Datadog, HPE, Summit Therapeutics, Carnival, POSCO, Wynn Resorts, SharkNinja, and Snap
Kraken partners with Alpaca to offer seamless access to hundreds of cryptocurrencies through Alpaca's Broker API, expanding its regulated trading capabilities.
Top mid-cap stocks gain, led by energy companies due to increased oil prices from Middle East conflict. Oklo, Bausch Health, Quantum Computing among top performers.
GTBP announces completion of dosing in Cohort 1 and start of dosing in Cohort 2 of Phase 1 trial for GTB-3650, showing potential for NK cell expansion and increased immunologic activity. Detailed results to be released in 2025. GTBP stock up 0.90%.
Realty Income Corp (NYSE: O) shares down premarket as Q4 AFFO misses consensus. Annualized rent on re-leases up, occupancy rate at 98.7%. Dividend raised and share repurchase program authorized.
